Is Better Therapeutics, Inc. (BTTX) a Buy, Sell, or Hold?
OTC : BTTX
Better Therapeutics, Inc. — Insider Trades
$0.0001 USD
$0 (0.0%)
- Volume
- 3K
- Average Volume
- 4.11K
- Market Capitalization
- $5.45K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.00
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $1.37
Insider Activity Summary (Last 12 Months)
Insiders Buying
32
Insiders Selling
5
Amount of Insider Selling
$36850
BTTX Insider Buying/Selling by Quarter
BTTX Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| PERRY DAVID P | director, 10 percent owner, officer: Executive Chairman | 2024-02-09 | A-Award | 0.1905 | 2024-02-13 |
| PERRY DAVID P | director, 10 percent owner, officer: Executive Chairman | 2024-01-09 | A-Award | 0.1699 | 2024-01-10 |
| PERRY DAVID P | director, 10 percent owner, officer: Executive Chairman | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| Carmona Richard H | director | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| LAVIZZO-MOUREY RISA J | director | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| Wynholds Kristin | officer: Chief Product Officer | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| Parker Geoffrey M. | director | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| Armanino Andrew J. | director | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| Miller Leslie A. | officer: Principal Accounting Officer | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| Granger Elder | director | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| KARBE FRANK | director, officer: Chief Executive Officer | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| Berman Mark A. | officer: Chief Medical Officer | 2023-12-18 | A-Award | 0 | 2023-12-20 |
| Miller Leslie A. | officer: Principal Accounting Officer | 2023-11-27 | 0 | 2023-12-07 | |
| Miller Leslie A. | officer: Principal Accounting Officer | 2023-11-27 | 10.97 | 2023-12-07 | |
| Miller Leslie A. | officer: Principal Accounting Officer | 2023-11-27 | 1.97 | 2023-12-07 | |
| Miller Leslie A. | officer: Principal Accounting Officer | 2023-11-27 | 1.14 | 2023-12-07 | |
| PERRY DAVID P | director, 10 percent owner, officer: Executive Chairman | 2023-07-27 | P-Purchase | 0.7299 | 2023-07-31 |
| Berman Mark A. | officer: Chief Medical Officer | 2023-07-27 | P-Purchase | 0.7299 | 2023-07-31 |
| Armanino Andrew J. | director | 2023-07-27 | P-Purchase | 0.7299 | 2023-07-31 |
| Granger Elder | director | 2023-07-27 | P-Purchase | 0.7299 | 2023-07-31 |
| KARBE FRANK | director, officer: Chief Executive Officer | 2023-07-27 | P-Purchase | 0.7299 | 2023-07-31 |
| Parker Geoffrey M. | director | 2023-07-27 | P-Purchase | 0.7299 | 2023-07-31 |
| Carmona Richard H | director | 2023-06-07 | A-Award | 0.77 | 2023-06-09 |
| Granger Elder | director | 2023-06-07 | A-Award | 0.77 | 2023-06-09 |
| Armanino Andrew J. | director | 2023-06-07 | A-Award | 0.77 | 2023-06-09 |
| LAVIZZO-MOUREY RISA J | director | 2023-06-07 | A-Award | 0.77 | 2023-06-09 |
| Parker Geoffrey M. | director | 2023-06-07 | A-Award | 0.77 | 2023-06-09 |
| PERRY DAVID P | director, 10 percent owner, officer: Executive Chairman | 2023-06-07 | A-Award | 0.77 | 2023-06-09 |
| Granger Elder | director | 2023-05-16 | P-Purchase | 0.8672 | 2023-05-18 |
| Heinen Mark | officer: Chief Financial Officer | 2023-04-05 | A-Award | 0 | 2023-04-21 |
| Heinen Mark | officer: Chief Financial Officer | 2023-03-01 | A-Award | 1.14 | 2023-04-21 |
| Wynholds Kristin | officer: Chief Product Officer | 2023-04-05 | A-Award | 0 | 2023-04-21 |
| Wynholds Kristin | officer: Chief Product Officer | 2023-03-01 | A-Award | 1.14 | 2023-04-21 |
| Berman Mark A. | officer: Chief Medical Officer | 2023-04-05 | A-Award | 0 | 2023-04-21 |
| Berman Mark A. | officer: Chief Medical Officer | 2023-03-01 | A-Award | 1.14 | 2023-04-21 |
| Georgianna Maule-Ffinch 2015 Trust | 10 percent owner | 2023-04-10 | 0 | 2023-04-17 | |
| PERRY DAVID P | director, 10 percent owner, officer: See Remarks | 2023-04-10 | P-Purchase | 0.825 | 2023-04-12 |
| PERRY DAVID P | director, 10 percent owner, officer: See Remarks | 2023-04-10 | P-Purchase | 0.825 | 2023-04-12 |
| KARBE FRANK | director, officer: See Remarks | 2023-04-10 | P-Purchase | 0.825 | 2023-04-12 |
| Parker Geoffrey M. | director | 2023-04-10 | P-Purchase | 0.825 | 2023-04-12 |
| Armanino Andrew J. | director | 2023-04-10 | P-Purchase | 0.825 | 2023-04-12 |
| Wynholds Kristin | officer: Chief Product Officer | 2022-11-30 | A-Award | 1.241 | 2022-12-02 |
| Wynholds Kristin | officer: Chief Product Officer | 2022-05-31 | A-Award | 1.5385 | 2022-12-02 |
| Heinen Mark | officer: See Remarks | 2022-11-30 | A-Award | 1.241 | 2022-12-02 |
| PERRY DAVID P | director, 10 percent owner, officer: See Remarks | 2022-09-16 | P-Purchase | 2.068 | 2022-09-19 |
| PERRY DAVID P | director, 10 percent owner, officer: See Remarks | 2022-09-15 | P-Purchase | 1.994 | 2022-09-19 |
| KARBE FRANK | director, officer: See Remarks | 2022-09-15 | P-Purchase | 2.0939 | 2022-09-15 |
| Heinen Mark | officer: See Remarks | 2022-09-13 | P-Purchase | 1.94 | 2022-09-14 |
| Heinen Mark | officer: See Remarks | 2022-09-12 | P-Purchase | 1.94 | 2022-09-14 |
| KARBE FRANK | director, officer: See Remarks | 2022-07-05 | A-Award | 1.68 | 2022-07-07 |
| KARBE FRANK | officer: See Remarks | 2022-07-05 | A-Award | 0 | 2022-07-07 |
| KARBE FRANK | director, officer: See Remarks | 2022-07-05 | 0 | 2022-07-07 | |
| Heinen Mark | officer: See Remarks | 2022-06-24 | P-Purchase | 1.7539 | 2022-06-28 |
| Armanino Andrew J. | director: | 2022-06-14 | P-Purchase | 1.3897 | 2022-06-16 |
| Parker Geoffrey M. | director: | 2022-06-13 | P-Purchase | 1.4473 | 2022-06-14 |
| Heinen Mark | officer: See Remarks | 2022-06-10 | P-Purchase | 1.56 | 2022-06-10 |
| Granger Elder | director: | 2022-06-09 | A-Award | 0 | 2022-06-10 |
| Granger Elder | director | 2022-06-09 | A-Award | 1.66 | 2022-06-10 |
| Parker Geoffrey M. | director: | 2022-06-09 | A-Award | 0 | 2022-06-10 |
| Parker Geoffrey M. | director | 2022-06-09 | A-Award | 1.66 | 2022-06-10 |
| Liu Suying | director: | 2022-06-09 | A-Award | 0 | 2022-06-10 |
| LAVIZZO-MOUREY RISA J | director: | 2022-06-09 | A-Award | 0 | 2022-06-10 |
| LAVIZZO-MOUREY RISA J | director | 2022-06-09 | A-Award | 1.66 | 2022-06-10 |
| Carmona Richard H | director | 2022-06-09 | A-Award | 1.66 | 2022-06-10 |
| Carmona Richard H | director: | 2022-06-09 | A-Award | 0 | 2022-06-10 |
| Armanino Andrew J. | director: | 2022-06-09 | P-Purchase | 1.6542 | 2022-06-10 |
| Armanino Andrew J. | director | 2022-06-09 | A-Award | 1.66 | 2022-06-10 |
| Armanino Andrew J. | director: | 2022-06-09 | A-Award | 0 | 2022-06-10 |
| PERRY DAVID P | officer: See Remarks | 2022-06-09 | A-Award | 0 | 2022-06-10 |
| Zamirowski Justin | officer: Chief Commercial Officer | 2022-05-27 | M-Exempt | 0.5 | 2022-06-01 |
| Zamirowski Justin | officer: Chief Commercial Officer | 2022-05-16 | M-Exempt | 0 | 2022-05-18 |
| Wynholds Kristin | officer: Chief Product Officer | 2022-04-01 | A-Award | 0 | 2022-04-04 |
| Zamirowski Justin | officer: Chief Commercial Officer | 2022-04-01 | A-Award | 0 | 2022-04-04 |
| Berman Mark A. | officer: Chief Medical Officer | 2022-04-01 | A-Award | 0 | 2022-04-04 |
| Heinen Mark | officer: See Remarks | 2022-03-31 | A-Award | 0 | 2022-04-04 |
| Heinen Mark | officer: See Remarks | 2022-03-31 | P-Purchase | 1.98 | 2022-04-04 |
| Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended | director: | 2022-03-31 | A-Award | 0 | 2022-04-04 |
| Kevin Appelbaum, or his successor(s), as Trustee of the Kevin Appelbaum Revocable Trust under Revocable Trust Declaration dated 5/16/2020, as amended | director: | 2022-03-31 | P-Purchase | 1.9685 | 2022-04-04 |
| Armanino Andrew J. | director: | 2022-03-29 | P-Purchase | 2.1405 | 2022-03-31 |
| Parker Geoffrey M. | director: | 2022-03-29 | P-Purchase | 2.1487 | 2022-03-31 |
| LAVIZZO-MOUREY RISA J | director | 2021-12-21 | P-Purchase | 4.6 | 2021-12-23 |
| Appelbaum Kevin J | director, 10 percent owner, officer: Chief Executive Officer | 2021-12-20 | P-Purchase | 4.5999 | 2021-12-22 |
| Appelbaum Kevin J | director, 10 percent owner, officer: Chief Executive Officer | 2021-12-15 | P-Purchase | 4.7065 | 2021-12-17 |
| Parker Geoffrey M. | director | 2021-12-14 | P-Purchase | 4.94 | 2021-12-16 |
| Heinen Mark | officer: See Remarks | 2021-12-15 | P-Purchase | 4.695 | 2021-12-15 |
| Heinen Mark | officer: See Remarks | 2021-12-14 | P-Purchase | 5.4424 | 2021-12-15 |
| Heinen Mark | officer: See Remarks | 2021-12-13 | P-Purchase | 5.45 | 2021-12-15 |
| Armanino Andrew J. | director | 2021-12-13 | P-Purchase | 5.4794 | 2021-12-15 |
| Appelbaum Kevin J | director, 10 percent owner, officer: Chief Executive Officer | 2021-12-10 | P-Purchase | 5.9752 | 2021-12-14 |
| Granger Elder | director | 2021-12-03 | P-Purchase | 6.66 | 2021-12-07 |
| Appelbaum Kevin J | director, 10 percent owner, officer: Chief Executive Officer | 2021-12-03 | P-Purchase | 6.426 | 2021-12-06 |
| Appelbaum Kevin J | director, 10 percent owner, officer: Chief Executive Officer | 2021-12-02 | P-Purchase | 6.84 | 2021-12-06 |
| Armanino Andrew J. | director | 2021-11-29 | P-Purchase | 6.96 | 2021-12-01 |
| Granger Elder | director | 2021-11-10 | A-Award | 10.14 | 2021-11-15 |
| Granger Elder | director: | 2021-11-10 | 0 | 2021-11-15 | |
| Carmona Richard H | director | 2021-10-28 | A-Award | 0 | 2021-11-01 |
| Carmona Richard H | director | 2021-10-28 | A-Award | 10.97 | 2021-11-01 |
| Liu Suying | director | 2021-10-28 | J-Other | 0 | 2021-11-01 |
| Liu Suying | director | 2021-10-28 | A-Award | 10.97 | 2021-11-01 |
| Liu Suying | director | 2021-10-28 | J-Other | 0 | 2021-11-01 |